Fadel R - Search Results

1

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study.

Guez S, Vatrinet C, Fadel R, André C. Guez S, et al. Among authors: fadel r. Allergy. 2000 Apr;55(4):369-75. doi: 10.1034/j.1398-9995.2000.00413.x. Allergy. 2000. PMID: 10782522 Clinical Trial.

2

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Pham-Thi N, et al. Among authors: fadel r. Pediatr Allergy Immunol. 2007 Feb;18(1):47-57. doi: 10.1111/j.1399-3038.2006.00475.x. Pediatr Allergy Immunol. 2007. PMID: 17295799 Clinical Trial.

3

Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study.

Leynadier F, Banoun L, Dollois B, Terrier P, Epstein M, Guinnepain MT, Firon D, Traube C, Fadel R, André C. Leynadier F, et al. Among authors: fadel r. Clin Exp Allergy. 2001 Jul;31(7):988-96. doi: 10.1046/j.1365-2222.2001.01145.x. Clin Exp Allergy. 2001. PMID: 11467988 Clinical Trial.

4

Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study.

Grosclaude M, Bouillot P, Alt R, Leynadier F, Scheinmann P, Rufin P, Basset D, Fadel R, André C. Grosclaude M, et al. Among authors: fadel r. Int Arch Allergy Immunol. 2002 Nov;129(3):248-53. doi: 10.1159/000066779. Int Arch Allergy Immunol. 2002. PMID: 12444323 Clinical Trial.

5

Anaphylaxis caused by allergen sublingual immunotherapy?

André C, Fadel R. André C, et al. Among authors: fadel r. Allergy. 2007 Oct;62(10):1220-1. doi: 10.1111/j.1398-9995.2007.01512.x. Allergy. 2007. PMID: 17845597 No abstract available.

6

Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.

Wüthrich B, Gumowski PL, Fäh J, Hürlimann A, Deluze C, André C, Fadel R, Carat F. Wüthrich B, et al. Among authors: fadel r. J Investig Allergol Clin Immunol. 2001;11(3):149-56. J Investig Allergol Clin Immunol. 2001. PMID: 11831445

7

House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.

Devillier P, Fadel R, de Beaumont O. Devillier P, et al. Among authors: fadel r. Allergy. 2016 Feb;71(2):249-57. doi: 10.1111/all.12791. Epub 2015 Nov 6. Allergy. 2016. PMID: 26465232 Clinical Trial.

8

House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma.

Wang L, Yin J, Fadel R, Montagut A, de Beaumont O, Devillier P. Wang L, et al. Among authors: fadel r. Allergy. 2014 Sep;69(9):1181-8. doi: 10.1111/all.12188. Epub 2014 Jul 24. Allergy. 2014. PMID: 25056584 Clinical Trial.

9

Immune mechanisms of allergen-specific sublingual immunotherapy.

Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L. Moingeon P, et al. Among authors: fadel r. Allergy. 2006 Feb;61(2):151-65. doi: 10.1111/j.1398-9995.2006.01002.x. Allergy. 2006. PMID: 16409190 Review.

10

Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.

Omnes LF, Bousquet J, Scheinmann P, Neukirch F, Jasso-Mosqueda G, Chicoye A, Champion L, Fadel R. Omnes LF, et al. Among authors: fadel r. Eur Ann Allergy Clin Immunol. 2007 May;39(5):148-56. Eur Ann Allergy Clin Immunol. 2007. PMID: 17626329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters